Cargando…
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
Graft versus host disease (GvHD) is the clinical condition in which bone marrow-derived mesenchymal stromal cells (MSCs) have been most frequently studied. In this review, we summarize the experience from clinical trials that have paved the way to translation. While MSC-based therapy has shown an ex...
Autores principales: | Kadri, Nadir, Amu, Sylvie, Iacobaeus, Ellen, Boberg, Erik, Le Blanc, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229573/ https://www.ncbi.nlm.nih.gov/pubmed/37165014 http://dx.doi.org/10.1038/s41423-023-01022-z |
Ejemplares similares
-
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study
por: Iacobaeus, Ellen, et al.
Publicado: (2019) -
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
por: Gavin, Caroline, et al.
Publicado: (2019) -
Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling
por: Gavin, Caroline, et al.
Publicado: (2019) -
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
por: Boberg, Erik, et al.
Publicado: (2023) -
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
por: Boberg, Erik, et al.
Publicado: (2020)